Abstract:AIM:To assess macular retinal microcirculatory changes in patients receiving hydroxychloroquine(HCQ)using optical coherence tomography angiography(OCTA)and to explore the potential value of OCTA for early screening of HCQ-related retinal toxicity.
METHODS: This was a retrospective case-control study. Patients with rheumatic autoimmune diseases who were regularly taking HCQ and had no obvious organic abnormalities on fundus examination were enrolled as the case group from January 2025 to March 2026 at the First People's Hospital of Lianyungang. Healthy participants matched for age, sex and other demographic characteristics were recruited as the control group(Group A). The case group was further divided into two subgroups according to HCQ treatment duration: duration <5 y(Group B)and duration ≥5 y(Group C). All participants underwent best-corrected visual acuity(BCVA), spectral-domain optical coherence tomography(SD-OCT), visual field and fundus examinations. OCTA was adopted to measure vessel density of the superficial capillary plexus(SCP)and deep capillary plexus(DCP), as well as the area, perimeter, vessel density and outer flow area of the foveal avascular zone(FAZ)in each region(fovea, parafovea and perifovea)within the 6 mm ×6 mm macular scan area. The above parameters were compared among the three groups. The correlations between regional retinal vessel density and HCQ treatment duration in the case group were analyzed.
RESULTS: Totally 60 participants(8 males and 52 females)were enrolled in this study, with a mean age of 43.53±9.67 y. Group A consisted of 19 participants(mean age 43.74±10.64 y; 3 males, 16 females), Group B consisted of 19 participants(mean age 43.74±12.70 y; 3 males, 16 females), and Group C consisted of 22 participants(mean age 43.82±6.84 y; 2 males, 20 females). Macular DCP vessel density was significantly lower in Group C than in Group A(P<0.05). SCP vessel density did not differ significantly among the three groups(all P>0.05).Regional DCP vessel density in the whole area, superior hemifield, inferior hemifield, fovea, parafovea, and perifovea was negatively correlated with HCQ treatment duration in HCQ-treated patients(rs=-0.176,-0.219,-0.184,-0.317,-0.436,-0.259, respectively; all P<0.05).
CONCLUSIONS:OCTA can detect decreased macular DCP vessel density in patients with rheumatic autoimmune diseases receiving long-term HCQ. DCP vessel density is negatively correlated with treatment duration, suggesting that OCTA has the potential to be an adjunctive tool for screening HCQ-related retinal toxicity.